New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - zidovudine 100mg - capsule - 100 mg - active: zidovudine 100mg excipient: gelatin ink magnesium stearate maize starch microcrystalline cellulose sodium starch glycolate - retrovir oral formulations are indicated in combination with other anti-retroviral agents for the treatment of human immunodeficiency virus (hiv) infection in adults and children.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - zidovudine 250mg - capsule - 250 mg - active: zidovudine 250mg excipient: gelatin ink magnesium stearate maize starch microcrystalline cellulose sodium starch glycolate - retrovir oral formulations are indicated in combination with other anti-retroviral agents for the treatment of human immunodeficiency virus (hiv) infection in adults and children.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - zidovudine 10 mg/ml - oral solution - 10 mg/ml - active: zidovudine 10 mg/ml excipient: citric acid monohydrate glycerol hydrogenated glucose syrup purified water saccharin sodium sodium benzoate strawberry flavour phl-134189 white sugar flavour da13780 - retrovir oral formulations are indicated in combination with other anti-retroviral agents for the treatment of human immunodeficiency virus (hiv) infection in adults and children.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - zidovudine 10 mg/ml - solution for injection - 200mg/20ml - active: zidovudine 10 mg/ml excipient: hydrochloric acid sodium hydroxide water for injection - retrovir iv for infusion is indicated for the short-term management of serious manifestations of human immunodeficiency virus (hiv) infection in patients with acquired immune deficiency syndrome (aids), who are unable to take retrovir oral formulations.

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - zidovudine - capsules - zidovudine 100 mg - zidovudine - zidovudine - retrovir oral formulations are indicated in anti-retroviral combination therapy for human immunodeficiency virus (hiv) infected adults and children.retrovir chemoprophylaxis is indicated for use in hiv-positive pregnant women (over 14 weeks of gestation) for prevention of maternal-foetal hiv transmission and for primary prophylaxis of hiv infection in newborn infants.

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - zidovudine - capsules - zidovudine 250 mg - zidovudine - zidovudine - retrovir oral formulations are indicated in anti-retroviral combination therapy for human immunodeficiency virus (hiv) infected adults and children.retrovir chemoprophylaxis is indicated for use in hiv-positive pregnant women (over 14 weeks of gestation) for prevention of maternal-foetal hiv transmission and for primary prophylaxis of hiv infection in newborn infants.

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - zidovudine - solution for infusion - zidovudine 200 mg / 20 ml - zidovudine - zidovudine - retrovir iv for infusion is indicated for the short term management of serious manifestations of human immunodeficiency virus (hiv) infection in patients with acquired immuno deficiency syndrome (aids) or aids who are unable to take retrovir oral formulations.retrovir chemoprophylaxis, is indicated for use in hiv-positive pregnant women (over 14 weeks of gestation) for prevention of maternal-foetal hiv transmission and for primary prophylaxis of hiv infection in newborn infants. retrovir i.v. should only be used when oral treatment is not possible (except during labour and delivery).

Ireland - English - HPRA (Health Products Regulatory Authority)

viiv healthcare uk ltd - zidovudine - capsules hard - 100 milligram - nucleoside and nucleotide reverse transcriptase inhibitors

Ireland - English - HPRA (Health Products Regulatory Authority)

viiv healthcare uk ltd - zidovudine - concentrate for soln for inf - 10 mg/ml - nucleoside and nucleotide reverse transcriptase inhibitors

Ireland - English - HPRA (Health Products Regulatory Authority)

viiv healthcare uk ltd - zidovudine - tablets - 300 milligram